Cameroun : Les survivants d une agression militaire attendent justice - Cameroon reliefweb.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reliefweb.int Daily Mail and Mail on Sunday newspapers.
Punch Newspapers
Sections
Published 27 February 2021
It is the joy of every family for their relatives to be successful. When the successful family members are siblings, the excitement would be even more profound. In the entertainment industry, there are a number of siblings who are making waves in the showbiz. And for some of them, they ‘inherited’ the craft from their parents. TOFARATI IGE takes a look at some of them
Afolayan: Moji, Aremu, Kunle, Gabriel
The late legendary filmmaker, Ade Afolayan, aka Ade Love, would most likely be happy in his grave because some of his children have continued to solidify his legacy in the film industry.
Tiger Woods in hospital after major car crash, undergoes surgery for multiple leg injuries.
Quote: LOS ANGELES: Golfing champion Tiger Woods
was hospitalized in Los Angeles on Tuesday with severe leg injuries suffered when his car swerved off a road and rolled down a steep hillside, requiring rescue crews to pry him from the wreckage, authorities said. The injuries were not believed to be life-threatening, Los Angeles County Sheriff Alex Villanueva told a news conference hours later, adding that Woods was conscious and able to communicate when rescue personnel arrived.
The sheriff said there was no evidence of impairment when Woods was assessed by emergency workers at the scene, and that no blood samples were drawn by investigators after he was rushed by ambulance to the Harbor-UCLA Medical Center.
FDA approves Oncopeptides PEPAXTO ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO
), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that the U.S. Food and Drug Administration, FDA, has approved PEPAXTO (melphalan flufenamide, also known as melflufen), in combination with dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody.